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a b s t r a c t
Vaccinia virus mutants in which expression of the virion core protein gene E6R is repressed are defective
in virion morphogenesis. E6 deﬁcient infections fail to properly package viroplasm into viral membranes,
resulting in an accumulation of empty immature virions and large aggregates of viroplasm. We have
used immunogold electron microscopy and immunoﬂuorescence confocal microscopy to assess the
intracellular localization of several virion structural proteins and enzymes during E6R mutant infections.
We ﬁnd that during E6R mutant infections virion membrane proteins and virion transcription enzymes
maintain a normal localization within viral factories while several major core and lateral body proteins
accumulate in aggregated virosomes. The results support a model in which vaccinia virions are
assembled from at least three substructures, the membrane, the viroplasm and a “pre-nucleocapsid”,
and that the E6 protein is essential for maintaining proper localization of the seven-protein complex and
the viroplasm during assembly.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Poxviruses are large (130–375 kb) dsDNA containing viruses
that replicate in the cell cytoplasm. The most notorious human
pathogen within the family Poxviridae (genus Orthopoxvirus) is
variola virus, the causative agent of smallpox disease, which was
responsible for millions of deaths throughout history prior to its
eradication in the late 1970s. Vaccinia virus is a related orthopox-
virus originally isolated from nature that was used as a live vaccine
for eradication of smallpox and has served as the prototypical
poxvirus for laboratory study (Moss, 2013; Damon, 2013).
The vaccinia virion structure is both unique and complex
(Condit et al., 2006). The virion exists in two infectious forms
which differ by the number of membranes surrounding the
particle. The simplest form, called “mature virus” (MV), is a
360270250 nm brick shaped particle which comprises four
substructures: (1) a central folded tubular nucleocapsid structure
surrounded by (2) a biconcave, proteinaceous core wall ﬂanked by
(3) proteinaceous lateral bodies, all of which is surrounded by (4) a
single proteolipid membrane bilayer. A slightly more complex
infectious form of the virus, called “extracellular virus” (EV), is
essentially MV which acquires a second early endosome or Golgi-
derived, virus protein-containing membrane during exocytosis
from infected cells (Smith et al., 2002). Importantly, because the
virus must launch infection in the cytoplasm using a DNA genome,
the poxvirus virion contains a full complement of virus coded
enzymes required for synthesis and modiﬁcation of early
virus mRNAs.
Each of the four MV substructures can be thought of as carrying
out a speciﬁc function during the initial stages of infection. The MV
proteolipid membrane is responsible for virus attachment and
ultimately fusion either at the plasma membrane or with an
endocytic vesicle, resulting in primary uncoating and release of
the virion core and lateral bodies into the cell cytoplasm (Moss,
2006). The lateral bodies probably contain proteins for immediate
use as countermeasures against the cellular innate antiviral
response, analogous to the herpesvirus tegument (Kelly et al.,
2009; Schmidt et al., 2013). The core wall provides a compartment
for early virus transcription and possibly for export of mRNA into
the cytoplasm, analogous to the reovirus infectious subvirus
particle (Dryden et al., 1993; Mallardo et al., 2001; Mallardo
et al., 2002). The nucleocapsid is likely the primary site of early
virus gene transcription (McFadden et al., 2012).
MV contain approximately 70 proteins total, some of which can
be assigned to speciﬁc virion substructures (Condit et al., 2006). The
MVmembrane contains two major structural proteins, A14 and A17,
which form a disulﬁde bonded network surrounding the core, plus
an additional 20 membrane proteins involved in virus attachment,
fusion and entry (Krijnse-Locker et al., 1996; Wolffe et al., 1996;
Rodriguez et al., 1997; Betakova and Moss, 2000; Moss, 2006; Unger
et al., 2013). The virion core, including the lateral bodies, the core
wall and the nucleocapsid, contains approximately 50 proteins, only
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a few of which have been deﬁnitively assigned to core substruc-
tures. The inner nucleocapsid contains the viral genome and
transcription enzymes required for transcription of early viral genes
during the initial stages of infection (McFadden et al., 2012). The
nucleocapsid may contain major structural virus proteins as well;
the virus coded L4 protein is a prime candidate for a nucleocapsid
structural protein (Moussatche and Condit, 2014; Jesus et al., 2014).
The core wall comprises at least three major virion structural
proteins, A3, A10 and A4 (Ichihashi et al., 1984; Wilton et al.,
1995; Roos et al., 1996; Pedersen et al., 2000; Moussatche and
Condit, 2014). A3 has been localized to the inner surface of the core
wall, while A10 and A4 have been localized to the outer surface of
the core wall. Three proteins, including F17, have been deﬁnitively
assigned to the lateral bodies, though several others, including both
enzymes and structural proteins are candidates for lateral body
proteins (Schmidt et al., 2013).
Assembly of pox virions is a fascinating, complex and poorly
understood process (Condit et al., 2006). During the mid and late
stages of virus infection, virus “factories” are established in the cell
cytoplasm. Virus factories are distinguishable by ﬂuorescence
microscopy as DNA-containing foci and by electron microscopy
as areas of uniform, relatively low electron density devoid of
cellular organelles. As observed by electron microscopy, the ﬁrst
evidence of virion morphogenesis is the appearance within
factories of crescent structures (cupules in 3 dimensions) repre-
senting the precursors to the MV membrane (Dales and
Siminovitch, 1961). As the crescents grow to become circles
(spheres in three dimensions), they encapsidate “viroplasm”,
visible as material of uniform intermediate density. As the circles
approach closure they encapsidate DNA, visible as material of high
electron density spanning the membrane (Morgan, 1976). Closed
circles (spheres) are called immature virions (IV). Probably all IV
contain DNA condensed in a spherical “nucleoid” structure, how-
ever because the nucleoid is acentric it is visible in only some
sections of the IV, called IVN (IV with nucleoid) (Morgan et al.,
1955). Immature virions contain the majority of the MV mem-
brane proteins and all of the core proteins, and they are coated
with a honeycomb matrix of the viral D13 protein, which serves as
a membrane scaffold during assembly of IV (Heuser, 2005; Szajner
et al., 2005). IV undergo an apparently rapid transformation to
become MV. This transformation requires proteolysis of several
virion structural proteins catalyzed by one or two virion proteases
(Ansarah-Sobrinho and Moss, 2004a; Ansarah-Sobrinho and Moss,
2004b). During transformation into MV, D13 dissociates from the
membrane outer surface, additional membrane proteins become
associated with the virion outer surface and the internal viroplasm
and nucleoid are reorganized into lateral bodies, core wall and
nucleocapsid (Bisht et al., 2009). MV are transported away from
viral factories on cellular microtubules (Sanderson et al., 2000;
Ward, 2005).
Insight into the pox virion assembly process can be acquired by
using virus mutants defective in virion assembly. One class of
assembly mutants is characterized by an apparent defect in associa-
tion of viroplasm with growing crescents. Mutants in this class,
comprising virus genes encoding eight different virion core proteins,
F10, A30, G7, A15, D2, D3, J1, and E6, display an electron microscopic
phenotype characterized by the presence of partial or complete virion
membrane structures devoid of viroplasm, plus large aggregates of
material of uniform intermediate electron density presumed to be
unpackaged viroplasm. Products of seven of these eight genes, F10,
A30, G7, A15, D2, D3, and J1, form a physical complex in which all the
proteins are mutually interdependent on each other for stability, that
is, repression of synthesis of any member of the complex results in
destabilization of all other members of the complex (Szajner et al.,
2004). Despite the similar phenotype of E6 mutants, the E6 protein is
apparently not associated with the seven-protein complex, and
repression of E6 synthesis does not destabilize the other seven
proteins (Boyd et al., 2010b).
The E6R gene is transcribed late during infection and the E6
protein is packaged into virion cores (Resch et al., 2009; Boyd
et al., 2010a; Boyd et al., 2010b). The sublocalization of E6 within
cores, speciﬁcally lateral bodies, core wall or nucleocapsid, is
unknown. Two different types mutants exist affecting gene E6R,
temperature sensitive and inducible. One temperature sensitive
mutant in E6R, Cts52, has been characterized in detail (Boyd et al.,
2010a). Under non-permissive conditions, Cts52 produces E6
protein which is packaged into virions that are indistinguishable
from wild type virions using conventional preparation techniques
for electron microscopy, however the virions produced are tran-
scriptionally inactive and non-infectious. In the inducible mutants
the E6 protein is under lac operator-repressor control in the virus
genome such that under non-permissive conditions the E6 protein
is not synthesized (Resch et al., 2009; Boyd et al., 2010b). Under
these conditions, viroplasm does not associate with growing
membrane crescents and “empty IV” are produced along with
large aggregates of material resembling viroplasm, termed “aggre-
gated virosomes”.
In order to gain additional insight into the role of E6 in vaccinia
virus assembly, we have assessed the effect of repression of E6
synthesis on the intracellular localization of representatives of
each of the vaccinia virion sub structures, and on the distribution
of the seven-protein complex. Our results show that in the
absence of the E6 protein, localization of proteins associated with
some virion substructures is signiﬁcantly changed, while localiza-
tion of proteins associated with other substructures is not notice-
ably perturbed. The results support a model in which vaccinia
virions are assembled from at least three substructures, and that
the E6 protein is essential for maintaining proper localization of
the seven-protein complex and at least one of the three substruc-
tures during assembly.
Results
In the course of this work we have used a selection of
antibodies to detect proteins associated with each of the MV
substructures: membrane, lateral body, core wall and nucleocap-
sid. The antibodies used are listed in Table 1 and a graphical
representation of the localization of the target proteins in mature
virions is presented in Fig. 1.
Strategy for tracking virion structural proteins using
immunoﬂuorescence confocal microscopy and immunogold electron
microscopy
The catalog of antibodies used in this work comprises both
rabbit polyclonal and mouse monoclonal antibodies, permitting
simultaneous detection of two virus proteins using immunoﬂuor-
escence confocal microscopy. To determine the distribution of
virion structural proteins during infection in the absence of E6
protein, we tested most pairwise combinations of these antibodies
(Table S1). A subset of these tests selected to demonstrate the
major ﬁndings is presented in the body of the results below, while
numerous other combinations are presented as supplementary
data (Fig. S1). In all cases we compared wt infections with vE6i
infections done in the absence of inducer. Infections were done at
a moi of 1–2 so that uninfected cells could be observed simulta-
neously with infected cells. Infected cells were sampled at 9 hpi,
mid-way into the late phase of virus infection. A control experi-
ment demonstrates that when a vE6i infection is done in the
presence of inducer, the phenotype is indistinguishable from a wt
infection, demonstrating that the phenotypes observed for vE6i
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infections done in the absence of inducer are attributable to
repression of E6R gene expression (Fig. S2).
Immunogold electron microscopy was used as a complement to
immunoﬂuorescence confocal microscopy. In this case we infected
cells with vE6i in the absence of inducer at moi¼5 and prepared
samples for immunogold labeling and electron microscopy 21 h
post infection.
Localization of virion core and membrane proteins in the absence of
E6
To determine the fate of the major virion membrane and core
wall structural proteins in the absence of E6 protein, wt and vE6i
infections were done in the absence of inducer and stained for the
membrane proteins A17 and A14 and the core wall proteins A3, A4
and A10 (Fig. 2). Electron micrographs recapitulate the previously
reported vE6i phenotype, namely large aggregated virosomes and
empty membrane crescents and IVs (Fig. 2A). Immunogold labeled
electron micrographs of vE6i infections show that aggregated
virosomes label heavily with antibody to the core wall proteins
A3, A4 and A10, but not with the virion membrane protein, A14.
Antibody to A14 labels viral membranes in empty crescents and
empty IV. In confocal micrographs (Fig. 2B), viral factories are
detected by cytoplasmic DAPI staining. In wt infections the bulk of
both core wall proteins and membrane proteins were localized in
puncta in viral factories. Wild type infections also show numerous
mature virions appearing as small cytoplasmic puncta distant from
the factories that stain with antibody against either A10 or A17. Note
that many more mature virion particles stain with anti-A17 than
with anti-A10, and none stain with both. We presume that the A17
positive particles retain the virion membrane which occludes A10
from staining, while the A10 positive particles have lost the virion
membrane during detergent treatment, thus losing A17 staining
and revealing A10. Very few mature virions stain with anti-A14; we
presume that the A14-reactive epitope is occluded in mature
virions. In vE6i infections the virion membrane proteins A14 and
A17 maintain a wt staining pattern, namely puncta localized to virus
factories. In vE6i infections, the membrane scaffold protein D13 also
maintains a relatively normal punctate staining pattern in viral
factories, however some aggregation of D13 within and outside of
factories is also observed (Fig. S1D). By contrast, in vE6i infections,
all three virion core wall proteins, A10, A3 and A4, stain numerous
large and small spherical structures, many but not all of which are
localized to virus factories. Note that staining for A10 and A4 is
precisely overlapping (Fig. 2B) as is staining for A10 and A3 (Fig.
S1A). Comparing these results to electron micrographs shown in
Fig. 2A, we conclude that the large spherical structures visualized by
immunoﬂuorescence microscopy are identical to the aggregated
virosomes identiﬁed by electron microscopy, and that the aggre-
gated virosomes contain the major core wall structural proteins
A10, A3 and A4. Furthermore maintenance of a wt membrane
protein staining pattern in vE6i infections is consistent with the
formation of normal, A14-positive viral membrane crescents
observed by electron microscopy.
Virus transcription proteins remain localized to factories in the
absence of E6
To determine the fate of the virus transcription apparatus in the
absence of E6, vE6i infections were stained with antibodies against
D6, a subunit of the viral early transcription factor (Gershon and
Moss, 1990); H4, an early gene-speciﬁc subunit of the viral RNA
polymerase (Ahn et al., 1994); D12, a subunit of the viral mRNA
capping enzyme (Niles et al., 1989); and E4, a core RNA polymerase
subunit (Ahn et al., 1990) (Figs. 3 and S1B and C). Importantly,
whereas the D12 capping enzyme subunit and the E4 core RNA
polymerase subunit are expressed early and function throughout
infection, the D6 early transcription factor and H4 early gene-
speciﬁc RNA polymerase subunit are expressed at intermediate
and late times after infection when early gene expression has
ceased, and are presumably made speciﬁcally for incorporation
into virions (Yang et al., 2011). Samples for immunoﬂuorescence
Fig. 1. Localization of proteins in mature virions. A cross section of MV is shown
and known locations of proteins probed in this study are indicated. Assignment of
A30 to lateral bodies is preliminary but consistent with published immunogold




Protein Function/Location Type Source IF dilution EM dilution
A14 Membrane structural Mouse monoclonal Yan Xiang 1:250
A14 Membrane structural Rabbit polyclonal Paula Traktman 1:200
A17 Membrane structural Rabbit polyclonal Paula Traktman 1:500
D13 Membrane scaffold Rabbit polyclonal Bernard Moss 1:500 1:2000
A3 Core wall Rabbit polyclonal Bernard Moss 1:500 1:2000
A4 Core wall Rabbit polyclonal Mariano Esteban 1:900 1:1000
A10 Core wall Mouse monoclonal Yan Xiang 1:250
A10 Core wall Rabbit polyclonal Bernard Moss 1:250
A10 Core wall Rabbit polyclonal Mariano Esteban 1:2000
L4 Nucleocapsid Rabbit polyclonal Paula Traktman 1:1000
L4 Mucleocapsid Mouse monoclonal Richard Condit 1:250
F17 Lateral body Rabbit polyclonal Paula Traktman 1:900 1:2000
H4 Early RNA polymerase subunit Rabbit polyclonal Bernard Moss 1:500 1:50
D6 Early transcription factor Rabbit polyclonal Edward Niles 1:500 1:50
D12 Capping enzyme Rabbit polyclonal Edward Niles 1:500
E4 Core RNA polymerase subunit Rabbit polyclonal Stephen Broyles 1:500
A30 Seven protein complex Rabbit polyclonal Bernard Moss 1:250
A30 seven protein complex Rabbit polyclonal Paula Traktman 1:100
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confocal microscopy were also counter-stained with antibody
against the A10 core wall protein. Electron micrographs immuno-
gold labeled with antibody to D6 show clusters of D6 protein
within factories containing numerous empty viral membrane
crescents and IV (Fig. 3A). Labeling of aggregated virosomes with
anti-D6 antibody was sparse or at background levels. Using
confocal immunoﬂuorescence microscopy, in control wt infec-
tions, the bulk of A10, D6, H4, D12 and E4 staining is localized in
puncta in virus factories (Figs. 3B and S1B and C). In vE6i
infections, A10 staining is redistributed to aggregated virosomes
as before, however all of the transcription proteins maintain
punctate staining within virus factories. We conclude from these
experiments that whereas virion core wall proteins are mis-
localized in the absence of E6, transcription enzymes destined
for packaging into virions maintain their normal localization.
Localization of nucleocapsid and lateral body proteins in the absence
of E6
To determine the fate of other core structural components in
the absence of E6, vE6i infections were stained with antibodies
against L4, a nucleocapsid protein and F17, a lateral body protein
(Fig. 4). Samples for immunoﬂuorescence were counter-stained
with antibody against either the A3 or the A10 core wall proteins.
Immunogold labeling of electron micrographs demonstrates dense
labeling of aggregated virosomes with both anti-F17 and anti-L4 in
vE6i infections (Fig. 4A). Using confocal immunoﬂuorescence
microscopy, in control wt infections, L4 and F17 display punctate
staining in viral factories combined with diffuse staining through-
out the cytoplasm, while the A3 and A10 core wall proteins reveal
predominantly punctate staining in viral factories as observed
previously (Figs. 4B and S1D and E). (The diffuse staining with L4
and F17 antibodies is not observed in uninfected cells and there-
fore represents the authentic distribution of these proteins rather
than background. Uninfected cells staining only with DAPI but not
L4 are present in the vE6i infection in Fig. 4B and the wt infection
in Fig. 5B. Data demonstrating a lack of F17 staining in uninfected
cells is not shown.) In vE6i infections, the A3 and A10 core wall
proteins are re-localized into aggregated virosomes as expected. In
vE6i infections, neither L4 nor F17 maintain the normal punctate
staining in viral factories, but rather assume a predominantly
diffuse cytoplasmic staining. Both L4 and F17 seem to localize to
some extent to aggregated virosomes as revealed by the orange
appearance of the aggregated virosomes in the merged images. A
typical feature of vE6i infections is the apparent condensation of
DNA in puncta in factories as revealed by DAPI staining. Interest-
ingly, in vE6i infections, L4 colocalizes with these areas of DNA
condensation, consistent with the DNA binding properties of the
L4 protein. Combining the immunogold EM and immunoﬂuours-
cence confocal microscopy results, we conclude that both L4 and
F17 are mis-localized during a vE6i infection, losing their normal
punctate staining in viral factories and localizing both to aggre-
gated virosomes and diffusely throughout the cytoplasm.
Localization of the seven-protein complex in the absence of E6
The so-called “seven-protein complex” is comprised of F10,
A30, G7, A15, D2, D3, and J1. Mutants in most of the genes
encoding these proteins results in a phenotype similar to the
E6R mutant phenotype, speciﬁcally the presence of empty imma-
ture virions and aggregated virosomes (Szajner et al., 2004). To
determine the fate of the seven-protein complex in the absence of
E6, we stained vE6i infections with antibody to A30 (Figs. 5 and
S2E). For immunoﬂuorescence confocal microscopy, to determine
the relative localization of A30 with two other core proteins, we
Fig. 2. Localization of virion core and membrane proteins in the absence of E6. (A)
Immunogold labeling of cells infected with vE6i. Primary antibodies used are
indicated in each panel. a¼aggregated virosome; m¼viral membranes;
n¼nucleus. Scale bars¼1 μM. (B) Immunoﬂuorescence confocal microscopy of
cells infected with wt or vE6i. Primary antibodies used are indicated in each panel.
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Fig. 3. Virus transcription proteins remain localized to factories in the absence of E6. (A) Immunogold labeling of cells infected with vE6i. Primary antibody to D6 was used as
indicated in the panel. a¼aggregated virosome; m¼viral membranes; n¼nucleus. White arrowheads indicate clusters of gold particles within factories. Scale bar¼1 μM.
(B) Immunoﬂuorescence confocal microscopy of cells infected with wt or vE6i. Primary antibodies used are indicated in each panel.
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counter stained with antibody to either the A10 core wall protein
or the L4 nucleocapsid protein. In immunogold labeled electron
micrographs, aggregated virosomes were not labeled with anti-
A30 at levels above background (Fig. 5A). Instead, A30 was
detected throughout the cell cytoplasm. Interestingly, in areas
containing accumulations of viral crescent membranes, anti-A30
speciﬁcally decorated the membranes. Using immunoﬂuorescence
microscopy, in wt infections, A30 displayed punctate staining in
viral factories (Fig. 5B). In wt infections as previously described
A10 showed punctate staining in viral factories while L4 showed
punctate staining in viral factories superimposed on a more diffuse
cytoplasmic staining. In vE6i infections, A10 is localized to
aggregated virosomes as described previously. Also as described
previously, in vE6i infections L4 lost its normal punctate staining
in viral factories and instead assumed a predominantly diffuse
cytoplasmic staining with some concentration in aggregated viro-
somes and in condensed factory DNA. In vE6i infections, A30 lost
its punctate staining in viral factories and assumed a cytoplasmic
staining that is both diffuse and reticular. While there is some
concentration of A30 at the periphery of aggregated virosomes,
compared to other core proteins A30 seems to be excluded
from aggregated virosomes. Note in particular in the merged
image counterstained with L4 that the center of the larger
aggregated virosomes are green whereas the diffuse cytoplasmic
Fig. 4. Localization of nucleocapsid and lateral body proteins in the absence of E6. (A) Immunogold labeling of cells infected with vE6i. Primary antibodies used are indicated
in each panel. a¼aggregated virosome; m¼viral membranes; n¼nucleus. Scale bars¼1 or 2 μM as indicated. B) Immunoﬂuorescence confocal microscopy of cells infected
with wt or vE6i. Primary antibodies used are indicated in each panel.
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staining is orange, suggesting an exclusion of A30 from aggregated
virosomes. We conclude that in the absence of E6 protein, A30
loses its normal localization to viral factories and becomes
distributed throughout the cytoplasm, with some association with
viral membranes and no accumulation within aggregated
virosomes.
Fig. 5. Localization of the seven-protein complex in the absence of E6. (A) Immunogold labeling of cells infected with vE6i. Primary antibody to A30 was used as indicated in
the panel. a¼aggregated virosome; m¼viral membranes; n¼nucleus. Scale bar¼2 μM. (B) Immunoﬂuorescence confocal microscopy of cells infected with wt or vE6i.
Primary antibodies used are indicated in each panel.
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Discussion
To gain insight into the role of the vaccinia virus E6 protein during
infection, we have investigated the intracellular distribution of
numerous virion proteins during infection with an E6 mutant, vE6i,
in which expression of the E6R gene is repressed. We observed that
during E6 mutant infections, some proteins maintain their normal
intracellular localization while others are mis-localized (Fig. 6).
Proteins that maintain an apparently normal localization in viral
factories include viral membrane proteins (A14, A17) and a mem-
brane associated protein (D13) and viral transcription enzymes
destined to be packaged in virions including the early viral transcrip-
tion factor (D6 subunit), the early gene speciﬁc form of the viral RNA
polymerase (H4 subunit), the core RNA polymerase (E4 subunit) and
the mRNA capping enzyme (D12 subunit). By contrast, all other virus
structural proteins tested are mis-localized during a vE6i infection.
These include three core wall proteins (A3, A4 and A10), a nucleo-
capsid structural protein (L4), a lateral body protein (F17) and a
representative of the seven-protein complex (A30). The mis-
localization is characterized by the disappearance of the normal
punctate staining of viral factories and the appearance of aggregated
virosomes. Aggregated virosomes contain core wall proteins, a
nucleocapsid structural protein and a lateral body protein. The
seven-protein complex protein A30 assumes a diffuse/reticular
cytoplasmic localization and is excluded from aggregated virosomes.
These results demonstrate that the E6 protein exerts a selective
inﬂuence over localization of virion proteins during infection, affect-
ing most structural components of the virion core but not affecting
either virion membrane proteins or transcription enzymes.
The mechanism by which E6 affects protein localization during
vaccinia infection remains to be determined. Given the similarity
between the E6 mutant phenotype and the phenotypes of mutants in
the seven-protein complex, it seems likely that E6 functions on the
same pathway as the seven-protein complex in attaching viroplasm to
viral membranes. It is noteworthy that in the experiments reported
here, one component of the seven-protein complex, A30, assumes an
apparently random cytoplasmic distribution when E6 is absent during
infection, as opposed to its normal punctate localization to viral
factories. Electron microscopic analysis of wild type infections shows
that A30 localizes both to unpackaged viroplasm and viroplasm
packaged in IV (Szajner et al., 2001). A parsimonious interpretation
of these observations is that E6 directs the localization of the seven-
protein complex, and that when in the absence of E6 the seven-
protein complex is mis-localized, attachment of viroplasm to crescent
viral membranes is abrogated. There have been no reports of interac-
tions between E6 and any other virus or cellular proteins, including
members of the seven-protein complex, which could shed light on E6
function. Future investigations into the ﬁne localization of E6 and
members of the seven-protein complex in IVs and MVs, coupled with
reﬁned studies of interactions of E6 and seven-protein complex
members with each other and with both membrane and viroplasm
proteins should provide a clearer understanding of the role of these
proteins in virus assembly.
Based on the results reported here we reason that the vaccinia
virion is assembled from three substructures, the membrane, the
viroplasm and a structure we call “pre-nucleocapsid” (Fig. 7). The
membrane contains the full complement of membrane proteins
scaffolded on the D13 protein as previously described (Heuser, 2005;
Szajner et al., 2005). Viroplasm comprises most if not all of the
remaining virion structural proteins, including both core wall proteins
(e.g. A3, A4, A10), lateral body proteins (e.g. F17) and nucleocapsid
structural proteins (e.g. L4). In this regard we perceive the aggregated
virosomes formed in vE6i infections not as completely aberrant
structures but rather as relatively normal viroplasm that accumulates
to abnormally large aggregates when unbounded by viral membranes.
We envision the pre-nucleocapsid to contain a complex of viral DNA
with transcription enzymes including the viral early transcription
factor, RNA polymerase, mRNA capping enzyme, and likely other
transcription and/or RNA modiﬁcation enzymes as well. We presume
that the pre-nucleocapsid is formed and enters maturing IVs at a late
stage, independently of the action of E6 or the seven-protein complex.
This is consistent with previous studies suggesting that the transcrip-
tion apparatus enters IV complexed with viral DNA (Zhang et al., 1994;
McFadden et al., 2012). Interestingly, L4, which we believe is a major
structural component of the nucleocapsid (Jesus et al., 2014;
Moussatche and Condit, 2014), does not appear to co-localize with
the pre-nucleocapsid but rather seems to be a component of viro-
plasm. This suggests that the ﬁnal nucleocapsid structure is assembled
during the IV to MV transition using components that enter IVs
separately as viroplasm or pre-nucleocapsid.
Detailing further the assembly of poxvirus immature virions and
the remarkable morphogenesis of immature virions into mature
virions remains a fascinating and rewarding challenge for the future.
Materials and methods
Cells and viruses
Viruses were grown in BSC-40 cells cultured in Dulbecco's Mod-
iﬁed Eagle's medium (Life Technologies – cat 12100-061) containing
Fig. 6. An illustration summarizing the phenotype of infection in the absence of
E6R gene expression. Factories contain empty viral membrane crescents and IV.
Factories also contain viral transcription enzymes and DNA normally destined for
packaging. Aggregated virosomes accumulate in factories of randomly in cyto-
plasm. The protein composition of aggregated virosomes is shown. F17 and L4
show some diffuse cytoplasmic localization in addition to localizing to virosomes.
A30 is diffuse throughout the cytoplasm.
Fig. 7. A model for vaccinia virion morphogenesis. Immature virions are assembled
from three subcomponents: the membrane, the core and the pre-nucleocapsid.
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10% fetal bovine serum, 0.12 mg/ml penicillin (Sigma), 0.2 mg/ml
streptomycin (Sigma) and 250 μg/ml fungizone (Sigma). Wild-type
vaccinia virus strain WR and vE6i have been described (Condit and
Motyczka, 1981; Boyd et al., 2010b). When IPTG was included in vE6i
infections, it was used at a ﬁnal concentration of 100 μM.
Immunogold electron microscopy
The procedure for immunogold labeling of virus infected cells
has been described previously (Jesus et al., 2014). Brieﬂy, conﬂuent
monolayers of BSC-40 cells in 35 mm dishes were infected at
moi¼5 with vE6i in the absence of the inducer for 21 h at 37 1C.
Infected cells were then washed with PHEM buffer (60 mM PIPES
[piperazine-N,N0-bis(2-ethanesulfonic acid)], 25 mM HEPES, 10 mM
EGTA, 2 mM MgCl2, pH 6.9) and ﬁxed with a solution containing
0.6% glutaraldehyde, 4% paraformaldehyde, 5 mM CaCl2, and 0.5%
sucrose in PHEM buffer for 1 h at 4 1C. The monolayer was washed
with 0.1 M glycine in PHEM buffer and cells were harvested by low
speed centrifugation. The cell pellets were dehydrated in a dilution
series of ice-cold ethanol, inﬁltrated with Lowicryl HM20 resin, and
polymerized with 100% Lowicryl at 20 1C with UV light for 2 days.
Ultrathin sections were collected on nickel grids and prepared for
immunolabeling by incubating the grids with 200 mM NH4Cl in PBS
(20.8 mM Na2HPO4, 6.4 mM KH2PO4, 300 mM NaCl, 40 mM NaN3,
pH 7.2) for 20 min, then in blocking solution (0.5 g BSA,0.5 g ﬁsh
skin gelatin 0.01% Tween 20, 0.1% NP40, in PBS) for 1 h. After this
period the grids were incubated overnight at 4 1C in antibodies
diluted in blocking solution as indicated in Table 1. After this time
the grids were washed twice in PBS for 20 min each, once in in
blocking solution for 5 min, and in the gold conjugated goat-anti-
rabbit (1:50) (BBI Solutions, Cardiff, United Kingdom) secondary
antibody for 2 h. After this period the grids were washed twice in
PBS for 20 min each, ﬁxed in McDowell and Trumps ﬁxative
(Electronic Microscopy Science) diluted 1:4 for 5 min, washed once
in H2O for 5 min, incubated in 1% uranyl acetate for 1 min, dried and
examined with an H-7000 transmission electron microscope (Hita-
chi High Technologies America, Inc., Schaumburg, IL).
Immunoﬂuorescence confocal microscopy
BSC-40 cell monolayers were grown in 8 well culture slides (BD
Falcon cat # 354108) and infected with 100 μl per well of virus in
phosphate buffered saline (PBS; 0.17 M NaCl, 3.3 mM KCl, 10 mM
Na2HPO4, 1.8 mM KH2PO4; pH 7.2) at an moi of 1–2. (The low MOI
infection provides control uninfected cells in each sample.) After
30 min adsorption, the inoculum was removed, cells were washed
twice with 400 μl per well PBS and 0.4 ml medium with or without
IPTG was added per well. After 9 h of incubation at 37 1C, infected
cells were processed for confocal microscopy. All the steps were
done at room temperature. Medium was removed, cells were
washed once with 400 μl per well PBS and ﬁxed with 200 μl per
well 4% paraformaldehyde in PBS for 10 min. The ﬁxative was
removed, cells were washed once with 400 μl per well PBS and
then incubated for 5 min with 400 μl PBS containing 20 mM glycine
per well to quench any remaining ﬁxative. Cells were washed once
with 400 μl PBS per well and permeabilized by addition of 200 μl per
well of 0.2% Triton X-100 in PBS for 10 min. Cells were washed twice
with 400 μl per well PBS, then blocked with 400 μl per well PBS
containing 10% fetal bovine serum (FBS) for 10 min. Cells were then
incubated with 100 μl per well primary antibody in PBS containing
0.1% Triton X-100 and 10% FBS for 60 min. Cells were washed three
times with 400 μl per well PBS followed by incubation with 100 ul
per well secondary antibody in PBS containing 0.1% Triton X-100 and
10% FBS for 30 min. Cells were washed twice with 400 μl per well
PBS and stained with 200 μl per well 0.5 mg/ml DAPI (Invitrogen) in
PBS for 15 min. Cells were washed three times with 400 μl per well
PBS, plastic culture chambers were removed from the slides and
coverslips were afﬁxed using 7 μl per well vectashield (Vector
Laboratories, Burlingame, CA). Samples were visualized with a LEICA
TCS SP2 AOBS Spectral Confocal microscope (Leica Microsystems
Inc., Buffalo Grove, IL). Sources and dilutions of primary antibodies
are listed in Table 1. Secondary antibodies Invitrogen, Carlsbad, CA)
Alexaﬂuor 488 goat anti-mouse IgG (cat #A11001), Alexaﬂuor 488
goat anti-rabbit IgG (cat #A11008), Alexaﬂuor 594 goat anti-mouse
IgG (cat #A11005), and Alexaﬂuor 594 goat anti-rabbit IgG (cat
#A11012) were used at 100 dilution.
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